Dermapharm Holding SE (FRA:DMP)
Germany · Delayed Price · Currency is EUR 35.05
+0.05 (0.14%)
At close: Jan 30, 2026
Dermapharm Holding SE Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 116.03 | 113.79 | 62.37 | 134.24 | 209.58 | 85.83 |
Depreciation & Amortization | 33.55 | 34.93 | 33.38 | 23.7 | 20.66 | 19.17 |
Other Amortization | 43.53 | 43.53 | 52.57 | 27.73 | 24.59 | 24.67 |
Loss (Gain) From Sale of Assets | 2.99 | 2.72 | -2.57 | -0.2 | -0.4 | -0.14 |
Asset Writedown & Restructuring Costs | 8.32 | 8.32 | 15.82 | 43.48 | 9.91 | 3.58 |
Loss (Gain) on Equity Investments | -1.13 | -1.52 | 7.16 | 13.54 | -0.32 | 1.5 |
Other Operating Activities | -0.95 | 17.67 | 41.65 | 50.18 | 32.62 | 10.3 |
Change in Other Net Operating Assets | 4.16 | -18.06 | 9.04 | -4.14 | -46.27 | -13.81 |
Operating Cash Flow | 206.5 | 201.38 | 219.42 | 288.53 | 250.37 | 131.1 |
Operating Cash Flow Growth | 4.95% | -8.22% | -23.95% | 15.24% | 90.98% | 30.30% |
Capital Expenditures | -42.11 | -38.24 | -41.54 | -39.01 | -61.2 | -40.8 |
Sale of Property, Plant & Equipment | 0.8 | 3.79 | 2.82 | 0.68 | 2.52 | 0.58 |
Cash Acquisitions | - | - | -389.4 | -69.79 | -22.51 | -68.83 |
Investment in Securities | -8.79 | 0.3 | 7.95 | 3.93 | -48.25 | - |
Other Investing Activities | 4.28 | 4.53 | 4.74 | 5.18 | 0.1 | 3.13 |
Investing Cash Flow | -45.83 | -29.61 | -415.43 | -99.01 | -129.35 | -105.91 |
Long-Term Debt Issued | - | 111.17 | 715 | 469.95 | 10 | 58.44 |
Long-Term Debt Repaid | - | -219.3 | -420.86 | -541.19 | -35.91 | -6.79 |
Net Debt Issued (Repaid) | -20.49 | -108.13 | 294.14 | -71.24 | -25.91 | 51.65 |
Common Dividends Paid | -48.46 | -47.38 | -56.53 | -116.83 | -47.38 | -43.07 |
Other Financing Activities | -61.74 | -53.66 | -33.07 | -11.69 | -7.69 | -22.67 |
Financing Cash Flow | -130.69 | -209.17 | 204.54 | -199.77 | -80.98 | -14.09 |
Foreign Exchange Rate Adjustments | -1.73 | -0.04 | -0 | -0.15 | 1.07 | -0.62 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | -0.83 | - | 0 | 0.83 |
Net Cash Flow | 28.26 | -37.44 | 7.7 | -10.4 | 41.11 | 11.31 |
Free Cash Flow | 164.39 | 163.14 | 177.88 | 249.52 | 189.17 | 90.3 |
Free Cash Flow Growth | 4.64% | -8.29% | -28.71% | 31.91% | 109.48% | 66.70% |
Free Cash Flow Margin | 14.00% | 13.65% | 15.46% | 23.98% | 19.70% | 11.17% |
Free Cash Flow Per Share | 3.05 | 3.03 | 3.30 | 4.63 | 3.51 | 1.68 |
Cash Interest Paid | 54.08 | 53.65 | 33.07 | 7.76 | 7.69 | 9.16 |
Cash Income Tax Paid | 99.75 | 83.84 | 65.37 | 40.59 | 44.85 | 38.19 |
Levered Free Cash Flow | 114.68 | 99.52 | 106.43 | 218.88 | 127.86 | 60.07 |
Unlevered Free Cash Flow | 147.35 | 136.03 | 140.78 | 226.59 | 133.38 | 65.92 |
Change in Working Capital | 4.16 | -18.06 | 9.04 | -4.14 | -46.27 | -13.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.